A new hope in the treatment of steroid-refractory graft versus host disease (Sr-GVHD) after allogeneic hematopoetic stem cell transplantation (AHSCT): Ruxolitinib

Access
info:eu-repo/semantics/closedAccessDate
2020Author
İlhan, OsmanCengiz Seval, Güldane
Civriz Bozdağ, Sinem
Deveci, Burak
Pehlivan, Mustafa
Kaynar, Leylagül
Yavaşoğlu, İrfan
Beköz, Hüseyin Saffet
Yönal Hindilerden, İpek
Yeğin, Zeynep Arzu
Dağdaş, Simten
Avşar, Ayşe
Özkan, Atilla Hasan
Fırat Tuğlular, Tülin
Göker, Hakan
Gülbaş, Zafer
Metadata
Show full item recordCitation
İlhan, O., Cengiz Seval, G., Civriz Bozdağ, S., Deveci, B., Pehlivan, M., Kaynar, L. ... Gülbaş, Z. (2020). A new hope in the treatment of steroid-refractory graft versus host disease (Sr-GVHD) after allogeneic hematopoetic stem cell transplantation (AHSCT): Ruxolitinib. Bone Marrow Transplantation içinde (329-330. ss.).Abstract
...
WoS Q Kategorisi
Q1Source
Bone Marrow TransplantationVolume
55Issue
SUPPL 1Collections
- Bildiri Koleksiyonu [478]
- WoS İndeksli Yayınlar Koleksiyonu [5526]